New arthritis injection trial halted before starting
NCT ID NCT05622175
Summary
This early-stage study aimed to test the safety and find the right dose of an experimental drug called F8IL10, given as injections directly into inflamed joints of people with rheumatoid arthritis. The trial was designed for patients whose arthritis flared up despite being on standard background medications. However, the study was withdrawn by the sponsor before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.